Observational studyGut2017

Effectiveness and safety of sofosbuvir plus ribavirin for the treatment of HCV genotype 2 infection: results of the real-world, clinical practice HCV-TARGET study.

Tania M Welzel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.